000 01494 a2200457 4500
005 20250511230259.0
264 0 _c19901121
008 199011s 0 0 eng d
022 _a0278-0232
024 7 _a10.1002/hon.2900080405
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDovey, G J
245 0 0 _aIfosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's disease.
_h[electronic resource]
260 _bHematological oncology
_c
300 _a205-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadministration & dosage
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMitoxantrone
_xadministration & dosage
650 0 4 _aNeoplasm Staging
700 1 _aChild, J A
700 1 _aSimmons, A V
700 1 _aBarnard, D L
700 1 _aParapia, L
700 1 _aMorgan, M
700 1 _aFletcher, J
700 1 _aParker, D
700 1 _aNorfolk, D R
700 1 _aStone, J
773 0 _tHematological oncology
_gvol. 8
_gno. 4
_gp. 205-13
856 4 0 _uhttps://doi.org/10.1002/hon.2900080405
_zAvailable from publisher's website
999 _c2216815
_d2216815